Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan N Becker

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Renal Failure|August 9, 2002
A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF)R Michael Hofmann, Christine Maloney, David M Ward, et al.
Molecular Pharmacology|January 27, 2004
The type 1 angiotensin II receptor tail affects receptor targeting, internalization, and membrane fusion propertiesBryan N Becker, Hui-fang Cheng, Timothy G Hammond, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
Rituximab as treatment for refractory kidney transplant rejectionYolanda T Becker, Bryan N Becker, John D Pirsch, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 18, 2011
The rationale, implementation, and effect of the Medicare CKD education benefitHenry N Young, Micah R Chan, Alex S Yevzlin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2002
Erythropoietin therapy may retard progression in chronic renal transplant dysfunctionBryan N Becker, Yolanda T Becker, Glen E Leverson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 22, 2004
Epithelial cell polarity and improved early outcomes in delayed graft function: a pilot study of polyclonal vs monoclonal antibodiesYolanda T Becker, R Michael Hofmann, Joseph Yracheta, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 29, 2007
Disease progression and outcomes in type 1 diabetic kidney transplant recipients based on posttransplantation CKD stagingChanigan Smavatkul, Julio Pascual, Anand G Desai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 12, 2011
Factors affecting employment at initiation of dialysisRebecca J Muehrer, Dori Schatell, Beth Witten, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 19, 2004
Intrathymic injection of anti-Fas monoclonal antibody prolongs murine non-vascularized cardiac allograft survivalArjang Djamali, Kenneth R Waller, Jonathan McAnulty, et al.
Seminars in Dialysis|December 8, 2006
Vascular access outcomes and medication use: a USRDS studyAlexander S Yevzlin, Emily L Conley, Robert J Sanchez, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Renal Failure|August 9, 2002
A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF)R Michael Hofmann, Christine Maloney, David M Ward, et al.
Molecular Pharmacology|January 27, 2004
The type 1 angiotensin II receptor tail affects receptor targeting, internalization, and membrane fusion propertiesBryan N Becker, Hui-fang Cheng, Timothy G Hammond, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
Rituximab as treatment for refractory kidney transplant rejectionYolanda T Becker, Bryan N Becker, John D Pirsch, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 18, 2011
The rationale, implementation, and effect of the Medicare CKD education benefitHenry N Young, Micah R Chan, Alex S Yevzlin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2002
Erythropoietin therapy may retard progression in chronic renal transplant dysfunctionBryan N Becker, Yolanda T Becker, Glen E Leverson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 22, 2004
Epithelial cell polarity and improved early outcomes in delayed graft function: a pilot study of polyclonal vs monoclonal antibodiesYolanda T Becker, R Michael Hofmann, Joseph Yracheta, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 29, 2007
Disease progression and outcomes in type 1 diabetic kidney transplant recipients based on posttransplantation CKD stagingChanigan Smavatkul, Julio Pascual, Anand G Desai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 12, 2011
Factors affecting employment at initiation of dialysisRebecca J Muehrer, Dori Schatell, Beth Witten, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 19, 2004
Intrathymic injection of anti-Fas monoclonal antibody prolongs murine non-vascularized cardiac allograft survivalArjang Djamali, Kenneth R Waller, Jonathan McAnulty, et al.
Seminars in Dialysis|December 8, 2006
Vascular access outcomes and medication use: a USRDS studyAlexander S Yevzlin, Emily L Conley, Robert J Sanchez, et al.
Pageof 8